| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | Formation of omeprazole sulphone but not 5-hydroxyomeprazole is inhibited by grapefruit juice. | Tassaneeyakul, W. Tassaneeyakul, W. Vannaprasaht, S. Yamazoe, Y. |
2000 | ||||
| 2. | The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity. | Gorski, J.C. Vannaprasaht, S. Ambrosius, W.T. Bruce, M.a. |
2003 | ||||
| 3. | Erratum: The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity (Clinical Pharmacology and Therapeutics (2003) 74 (275-287)) | Gorski, J.C. Vannaprasaht, S. Ambrosius, W.T. Bruce, M.a. |
2004 | ||||
| 4. | The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity (vol 74, pg 275, 2003) | JC Gorski S Vannaprasaht MA Hamman WT Ambrosius MA Bruce B Haehner-Daniels |
2004 | ||||
| 5. | Knowledge of epilepsy among teachers in Khon Kaen Province, Thailand | Tiamkao, S Aaauevitchayapat, N Arunpongpaisal, S Chaiyakum, A Jitpimolmard, S Phuttharak, W Phunikhom, K Saengsuwan, J Saetang, S Tiamkao, S Vannaprasaht, S |
2005 | ||||
| 6. | Steady-state bioequivalence study of clozapine tablet in schizophrenic patients | Tassaneeyakul, W Kittiwattanagul, K Vannaprasaht, S Kampan, J Tawalee, A Puapairoj, P Tiamkao, S Juthagridsada, S Kukongviriyapan, V Tassaneeyakul, W |
2005 | ||||
| 7. | Ceftazidime overdose-related nonconvulsive status epilepticus after intraperitoneal instillation | Vannaprasaht, S Tawalee, A Mayurasakorn, N Yodwut, C Bansong, R Reungjui, S Tiamkao, S |
2006 | ||||
| 8. | Seizure presenting to the emergency department, Srinagarind Hospital. | Tiamkao, S. Sawanyawisuth, K. Paowana, W. Saengsuwan, J. Arunpongpaisal, S. Chaiyakum, A. Phuttharak, W. Aaauevitchayapat, N. Vannaprasaht, S. Tiamkao, S. Phunikhom, K. Jitpimolmard, S. |
2006 | ||||
| 9. | Seizure-related injuries in northeast Thailand. | Tiamkao, S. Amornsin, O. Pongchaiyakul, C. Yaudnopakao, P. Jitpimolmard, S. Arunpongpaisal, S. Phuttharak, W. Aaauevitchayapat, N. Vannaprasaht, S. Tiamkao, S. Phunikhom, K. Chaiyakum, A. Saengsuwan, J. Saetang, S. |
2006 | ||||
| 10. | Basic knowledge of epilepsy among medical students | Tiamkao, S Tiamkao, S Auevitchayapat, N Arunpongpaisal, S Chaiyakum, A Jitpimolmard, S Phuttharak, W Phunikhom, K Saengsuwan M, J Vannaprasaht, S |
2007 | ||||
| 11. | Bioequivalence of Clozapine Tablet in Thai Schizophrenic Patients | Wichittra Tassaneeyakul Khanogwan Kittiwattanagul Siriporn Tiamkao Jureeporn Kampan Suda Vannaprasaht Wannapa Haewdee Prapawadee Puapairoj Bunkerd Kongyingyoes Wongwiwat Tassaneeyakul |
2007 | ||||
| 12. | COMPARATIVE BIOAVAILABILITY OF PHENYTOIN SUSPENSION IN THAI HEALTHY VOLUNTEERS | Suda Vannaprasaht Somsak Tiamkao Aporanee Chaiyakum Chedsada Noppawinyoowong Detpon Preechagoon Sirimas Kanjanawat Wichittra Tassaneeyakul |
2007 | ||||
| 13. | COMPARATIVE BIOAVAILABILITY OF TWO SILDENAFIL TABLET FORMULATIONS AFTER SINGLE-DOSE ADMINISTRATION IN HEALTHY THAI MALE VOLUNTEERS | Sirimas Kanjanawart Suda Vannaprasaht Panot Tangsucharit Dhanu Gaysornsiri Siriporn Tiamkao Bunkerd Kongyingyoes Roongpet Tangrassameeprasert Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2007 | ||||
| 14. | INHIBITORY EFFECT OF THAI MEDICINAL HERBS ON HUMAN CYTOCHROME P450 ACTIVITIES | Wichittra Tassaneeyakul Weeraya Dumrongsakunchai Vichien Attakornvattana Aimon Somanabandhu Suda Vannaprasaht Wongwiwat Tassaneeyakul |
2007 | ||||
| 15. | THIOPURINE S-METHYLTRANSFERASE POLYMORPHISM AS A PREDICTIVE MARKER FOR AZATHIOPRINE-INDUCED HEMATOTOXICITY IN KIDNEY TRANSPLANT RECIPIENTS | Susothorn Angsuthum Wichittra Tassaneeyakul Cholatip Pongskul Dhavee Sirivongs Wongwiwat Tassaneeyakul Yingyos Avihingsanon Suda Vannaprasaht |
2007 | ||||
| 16. | Very high dose phenobarbital for refractory status epilepticus | Tiamkao, S Mayurasakorn, N Suko, P Jitpimolmard, S Arunpongpaisal, S Phuttharak, W Auevitchayapat, N Vannaprasaht, S Tiamkao, S Phunikhom, K Chaiyakum, A Saengsuwan, J |
2007 | ||||
| 17. | Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism | U. Boonsrirat S. Angsuthum S. Vannaprasaht J. Konapurivijit N. Hirankarn W. Tassaneeyakul Y. Avihingsanon |
2008 | ||||
| 18. | Bioequivalence and Pharmacokinetic Study of Sildenafil in Healthy Thai Male Volunteers | Sirimas Kanjanawart Bunkerd Kongyingyoes Dhanu Gaysornsiri Panot Tangsucharit Prapawadee Puapairoj Suda Vannaprasaht Siriporn Tiamkao Wichittra Tassaneeyakul |
2008 | ||||
| 19. | Comparative bioavailability of two sertraline tablet formulations after single-dose administration in healthy Thai volunteers. | W. Tassaneeyakul S. Kanchanawat D. Gaysonsiri S. Vannaprasath R. Paupairoj K. Kittiwattanagul S. K. Tippabhotla A. Khuroo B. K. Panigrahy S. Reyar T. Monif |
2008 | ||||
| 20. | Acute valproic acid overdose: Enhance elimination with multiple-doses activated charcoal | Vannaprasaht, S Tiamkao, S Sirivongs, D Piyavhatkul, N |
2009 | ||||
| 21. | Bioequivalence study of two meloxicam tablet formulations after single-dose administration in healthy Thai male volunteers | Tangsucharit, P Kampan, J Kanjanawart, S Gaysonsiri, D Vannaprasaht, S Tiamkao, S Phunikhom, K Simasathiansophon, S Puapairoj, P Tassaneeyakul, W |
2009 | ||||
| 22. | Carbamazepine-the Most Common Cause of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis and an Association with HLA-B*1502 in a Thai Population | Thawinee Iantararoungtong Somsak Tiamkao Suda Vannaprasaht Kasemsin Pavakul Narong Auvichayapat Charoen Choonhakarn Wichittra Tassaneeyakul |
2009 | ||||
| 23. | Impact of the Heterozygous TPMT*1/*3C Genotype on Azathioprine-Induced Myelosuppression in Kidney Transplant Recipients in Thailand | Vannaprasaht, S Angsuthum, S Avihingsanon, Y Sirivongs, D Pongskul, C Makarawate, P Praditpornsilpa, K Tassaneeyakul, W Tassaneeyakul, W |
2009 | ||||
| 24. | Predictive risk factors of seizure-related injury in persons with epilepsy. | Tiamkao, S. Sawanyawisuth, K. Yaudnopakao, P. Arunpongpaisal, S. Phuttharak, W. Auevitchayapat, N. Vannaprasaht, S. Tiamkao, S. Phunikhom, K. Chaiyakum, A. Saengsuwan, J. Jitpimolmard, S. |
2009 | ||||
| 25. | PREDICTIVE RISKS OF SEIZURE-RELATED INJURY IN EPILEPTICS | K. Sawanyawisuth S. Arunpongpaisal W. Phuttharak N. Auevitchayapat S. Vannaprasaht S. Tiamkao K. Phunikhom A. Chaiyakum J. Saengsuwan |
2009 | ||||
| 26. | Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population | Tassaneeyakul, W Jantararoungtong, T Chen, P Lin, PY Tiamkao, S Khunarkornsiri, U Chucherd, P Konyoung, P Vannaprasaht, S Choonhakarn, C Pisuttimarn, P Sangviroon, A Tassaneeyakul, W |
2009 | ||||
| 27. | The influence of CYP2A6 polymorphisms and cadmium on nicotine metabolism in Thai population | Roongnapa Apinan Wichittra Tassaneeyakul Wiratchanee Mahavorasirikul Soisangwang Satarug Sirimas Kajanawart Suda Vannaprasaht Ronnatrai Ruenweerayut Kesara Na-Bangchang |
2009 | ||||
| 28. | Allopurinol -induced severe cutaneous adverse drug reactions in a Thai population is strongly associated with HLA-B*5801 | Wongwiwat Tassaneeyakul Somsak Tiamkao Napat Prabmeechai Thawinee Jantararoungtong Pei Chen Pao-Yu Lin Pansu Chumworathayi Usanee Khunarkornsiri Parinya Konyoung Pachadaporn Chucherd Suda Vannaprasaht Charoen Choonhakarn Alisara Sangviroon Wichittra Tassaneeyakul |
2010 | ||||
| 29. | Bioequivalence of 400 mg Moxifloxacin Tablet in Healthy Thai Volunteers | Sirimas Kanjanawart Sontaya Simasathiansopon Prapawadee Paupairoj Suda Vannaprasath Siriporn Tiamkao Dhanu Gaysonsiri Panot Tangsucharit Thanawat Kaewkamson Wichittra Tassaneeyakul |
2010 | ||||
| 30. | Comparative bioavailability of two risperidone orodispersible tablet products after single dose administration | Tassaneeyakul, W Kumar, S Gaysonsiri, D Kaewkamson, T Khuroo, A Tangsucharit, P Phunikhom, K Vannaprasaht, S Kanjanawart, S Rao Thudi, N Jain, R Reyar, S Monif, T |
2010 | ||||
| 31. | THIOPURINE S- METHYLTRANSFERASE PHARMACOGENETICS: FUNCTIONAL CHARACTERIZATION OF A NOVEL RAPIDLY DEGRADED VARIANT ALLOZYME. | Feng, Q. Vannaprasaht, S. Angsuthum, S. Avihingsanon, Y. Tassaneeyakul, W. |
2010 | ||||
| 32. | Comparative bioavailability of two sildenafil tablet formulations after single-dose administration in healthy Thai male volunteers | Kanjanawart, S Gaysonsiri, D Tangsucharit, P Vannaprasaht, S Phunikhom, K Kaewkamson, T Wattanachai, N Tassaneeyakul, W |
2011 | ||||
| 33. | Perinatal intraventricular hemorrhage (IVH) related to maternal warfarin | P. Komvilaisak P. Kiatchoosakun J. Jirapradittha A. Kitkhuandee S. Vannaprasaht |
2011 | ||||
| 34. | HLA-B*1502 Strongly Predicts Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Thai Patients with Neuropathic Pain | Kongkiat Kulkantrakorn Wichittra Tassaneeyakul Somsak Tiamkao Thawinee Jantararoungtong Napat Prabmechai Suda Vannaprasaht Pansu Chumworathayi Pei Chen Paskorn Sritipsukho |
2012 | ||||
| 35. | The Common Sodium Channel Promoter Haplotype in Thai Symptomatic Brugada Syndrome Patients | Pattarapong Makarawate Narumol Chaosuwannakit Suda Vannaprasaht Koo Seok Hwee Edmund Jon Deoon Lee Wichittra Tassaneeyakul |
2012 | ||||
| 36. | Comparative bioavailability of two moxifloxacin tablet products after single dose administration under fasting conditions in a balanced, randomized and cross-over study in healthy volunteers | Kanjanawart, S Gaysonsiri, D Phunikom, K Simasathiansopon, S Tangsucharit, P Vannaprasaht, S Kaewkamson, T Tassaneeyakul, W |
2013 | ||||
| 37. | Personalized Tacrolimus Doses Determined by CYP3A5 Genotype for Induction and Maintenance Phases of Kidney Transplantation | Vannaprasaht, S. Reungjui, S. Supanya, D. Sirivongs, D. Pongskul, C. Avihingsanon, Y. Tassaneeyakul, W. |
2013 | ||||
| 38. | SCN5A (H558R) gene mutation is associated with appropriate shock therapy in Thai Brugada syndrome patients receiving AICD treatment | P. Makarawate N. Chaosuwannakit S. Vannaprasaht K. Sawanyawisuth K. Seok Hwee E. Deoon Lee W. Tassaneeyakul |
2013 | ||||
| 39. | Clinical characteristics and treatment outcomes of patients with Brugada syndrome in northeastern Thailand | Makarawate, P Chaosuwannakit, N Vannaprasaht, S Tassaneeyakul, W Sawanyawisuth, K |
2014 | ||||
| 40. | Outcomes of symptomatic Brugada syndrome patients with implanted cardioverter defibrillators: A report from an endemic area | Makarawate, P. Chaosuwannakit, N. Vannaprasaht, S. Tassaneeyakul, W. Sawanyawisuth, K. |
2014 | ||||
| 41. | Pharmacokinetic Study and Therapeutic Drug Monitoring of Vancomycin in End Stage Renal Disease Patients | Teerapon Bootprom Weerapong Thumchotang Denpong Patanasethanont Aporanee Chaiyakum Siriluk Jaisue Suda Vannaprasaht |
2014 | ||||
| 42. | Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions. | Thachanan Kongpan Surakameth Mahasirimongkol Parinya Konyoung Sirimas Kanjanawart Pansu Chumworathayi Nuanjun Wichukchinda Runglak Kidkeukarun Suphanlinee Preechakul Usanee Khunarkornsiri Warawut Bamrungram Butsaban Supharatwattanakun Piroon Mootsikapun Supanida Kwangsukstid Sukanda Denjanta Suda Vannaprasaht Watcharee Rungapiromnan Wimon Suwankesawong Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2015 | ||||
| 43. | Genetic Markers for Severe Cutaneous Adverse Drug Reactions of Phenytoin | S. Tiamkao N. Prabmeechai P. Konyoung P. Chumworathayi C. Sukasem T. Kongpan N. Saksit A. Sangviroon S. Vannaprasath S. Kanjanawat N. Wichukchinda S. Mahasirimongkol W. Inunchot N. Chaiyakunapruk W. Tassaneeyakul |
2015 | ||||
| 44. | Non-BMPR2 mutation heritable pulmonary arterial hypertension in Southeast Asia. | Pussadhamma, B. Kiatchoosakun, S. Vannaprasaht, S. |
2015 | ||||
| 45. | The Effect of Genetic Polymorphism of CYP2C9 on Phenytoin Dosage Requirement in Thai Epileptic Patients | S. Vannaprasaht P. Sirisawat P. Chiewthanakul S. Tiamkao W. Tassaneeyakul |
2015 | ||||
| 46. | The impact of genetic polymorphisms of drug metabolizing enzymes on the pharmacodynamics of clopidogrel under steady state conditions. | Nakkam, N. Tiamkao, S. Kanjanawart, S. Tiamkao, S. Vannaprasaht, S. Tassaneeyakul, W. |
2015 | ||||
| 47. | Associations between HLA class i and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population | Tassaneeyakul, W Prabmeechai, N Sukasem, C Kongpan, T Konyoung, P Chumworathayi, P Tiamkao, S Khunarkornsiri, U Kulkantrakorn, K Saksit, N Nakkam, N Satapornpong, P Vannaprasaht, S Sangviroon, A Mahasirimongkol, S Wichukchinda, N Rerkpattanapipat, T Tassaneeyakul, W |
2016 | ||||
| 48. | Modified High Dose Omeprazole and Amoxicillin Triple Therapy Compare to Standard Triple Therapy in Helicobacter pylori Eradication | Uaepong Limpapanasit Pisaln Mairiang Kitti Chunlertlith Wattana Sukeepaisarnjaroen Suda Vannaprasaht Wichittra Tassaneeyakul Apichat Sangchan Kookwan Sawadpanich Tanita Suttichaimongkol |
2016 | ||||
| 49. | The Effect of CytidineDeaminase Polymorphisms on Hematotoxicity in Thai Cancer Patients Treated with Gemcitabine-based Chemotherapy | Duanggamon Muengsaen Suda Vannaprasaht Wichittra Tassaneeyakul Kritiya Butthongkomvong Thipawan Bowornkitiwong Luangyot Thongthieang Parichart Pongthai Kosin Wirasorn Aumkhae Sookprasert |
2016 | ||||
| 50. | Comparative pharmacodynamic effects of two clopidogrel formulations under steady-state conditions in healthy Thai volunteers | Nontaya Nakkam Somsak Tiamkao Sirimas Kanjanawart Kutcharin Phunikhom Siriporn Tiamkao Suda Vannaprasaht Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2017 | ||||
| 51. | Comparative pharmacodynamic effects of two clopidogrel formulations under steady-state conditions in healthy Thai volunteers . | Nakkam, N Tiamkao, S Kanjanawart, S Phunikhom, K Tiamkao, S Vannaprasaht, S Tassaneeyakul, W Tassaneeyakul, W |
2017 | ||||
| 52. | CYP2C9*3 VARIANT IS ASSOCIATED WITH PHENYTOIN-RELATED SEVERE CUTANEOUS ADVERSE REACTIONS IN A THAI POPULATION | Wichittra Tassaneeyakul Parinya Konyoung Thachanan Kongpan Pansu Chumworathayi Nontaya Nakkam Suda Vannaprasaht Somsak Tiamkao Chonlaphat Sukasem Patompong Satapornpong Wongwiwat Tassaneeyakul |
2017 | ||||
| 53. | Outcomes of a Randomized Controlled Trial Comparing Modified High Dose Omeprazole and Amoxicillin Triple Therapy with Standard Triple Therapy for Helicobacter Pylori Eradication | Mairiang, P. Vannaprasaht, S. Tassaneeyakul, W. Sangchan, A. Sawadpanich, K. |
2017 | ||||
| 54. | SCN5A genetic polymorphisms associated with increased defibrillator shocks in Brugada syndrome | Pattarapong Makarawate Narumol Chaosuwannakit Suda Vannaprasaht Dujdao Sahasthas Seok Hwee Koo Edmund Jon Deoon Lee Wichittra Tassaneeyakul Hector Barajas-Martinez Dan Hu Kittisak Sawanyawisuth |
2017 | ||||
| 55. | The impact of non-genetic and genetic factors on a stable warfarin dose in Thai patients | Nitsupa Wattanachai Sutthida Kaewmoongkun Burabha Pussadhamma Pattarapong Makarawate Chaiyasith Wongvipaporn Songsak Kiatchoosakun Suda Vannaprasaht Wichittra Tassaneeyakul |
2017 | ||||
| 56. | CYP2C19 loss-of-function alleles and clopidogrel hyporesponsiveness in patients with reinfarction/recurrent myocardial infarction after coronary stenting | Pussadhamma, B. Kiatchoosakun, S. Vannaprasaht, S. |
2018 | ||||
| 57. | Effect of CYP3A5 genotype on hospitalization cost for kidney transplantation. | Vannaprasaht, S. Limwattananon, C. Anutrakulchai, Chan-On, C. |
2019 | ||||
| 58. | Long term stability of immunophenotypic T cell subsets from whole blood of tacrolimus-based therapy kidney transplantation patients and healthy volunteers by flow cytometric analysis | Wongratanacheewin, S. Kaewraemruaen, C. Vannaprasaht, S. |
2019 | ||||
| 59. | Therapeutic concentration achievement and allograft survival comparing usage of conventional tacrolimus doses and CYP3A5 genotype-guided doses in renal transplantation patients. | Anutrakulchai, Pongskul, C. Kritmetapak , K Limwattananon, C. Vannaprasaht, S. |
2019 | ||||
| 60. | Intravascular hemolysis and methemoglobinemia from malacca fruit (Phyllanthus emblica) wine | Thapanawong Mitsungnern Nuttaphong Bummrungjitt Nattapat Wongtirawit Praew Kotruchin Suda Vannaprasaht |
2020 | ||||
| 61. | Total ophthalmoplegia with divergent gaze following severe amitriptyline toxicity: a case report | T. Mitsungnern N. Bummroongjitt N. Srimakam P. Kotruchin S. Vannaprasaht |
2020 | Count | 37 | 33 | 42 | 5 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | รวม | ||||||
| 1. | Formation of omeprazole sulphone but not 5-hydroxyomeprazole is inhibited by grapefruit juice | Tassaneeyakul, W. Tassaneeyakul, W. Vannaprasaht, S. Yamazoe, Y. |
2000 |
British Journal of Clinical Pharmacology 2 (49), pp. 139-144 |
||||||||
| 2. | The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity | Gorski, J.C. Vannaprasaht, S. Ambrosius, W.T. Bruce, M.a. |
2003 |
Clinical Pharmacology and Therapeutics 3 (74), pp. 275-287 |
||||||||
| 3. | Erratum: The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity (Clinical Pharmacology and Therapeutics (2003) 74 (275-287)) | Gorski, J.C. Vannaprasaht, S. Ambrosius, W.T. Bruce, M.a. |
2004 |
Clinical Pharmacology and Therapeutics 3 (75), pp. 249 |
||||||||
| 4. | Knowledge of epilepsy among teachers in Khon Kaen Province, Thailand | Tiamkao, S. Aaauevitchayapat, N. Arunpongpaisal, S. Chaiyakum, A. Jitpimolmard, S. Phuttharak, W. Phunikhom, K. Saengsuwan, J. Saetang, S. Tiamkao, S. Vannaprasaht, S. |
2005 |
Journal of the Medical Association of Thailand 12 (88), pp. 1802-1808 |
||||||||
| 5. | Steady-state bioequivalence study of clozapine tablet in schizophrenic patients | Tassaneeyakul, W. Kittiwattanagul, K. Vannaprasaht, S. Kampan, J. Tawalee, A. Puapairoj, P. Taimkao, S. Kukongviriyapan, V. Tassaneeyakul, W. |
2005 |
Journal of Pharmacy and Pharmaceutical Sciences 1 (8), pp. 47-53 |
||||||||
| 6. | Ceftazidime overdose-related nonconvulsive status epilepticus after intraperitoneal instillation | Vannaprasaht, S. Tawalee, A. Mayurasakorn, N. Yodwut, C. Bansong, R. Reungjui, S. Tiamkao, S. |
2006 |
Clinical Toxicology 4 (44), pp. 383-386 |
||||||||
| 7. | Seizure presenting to the emergency department, Srinagarind Hospital | Tiamkao, S. Sawanyawisuth, K. Paowana, W. Saengsuwan, J. Arunpongpaisal, S. Chaiyakum, A. Phuttharak, W. Aaauevitchayapat, N. Vannaprasaht, S. Tiamkao, S. Phunikhom, K. Jitpimolmard, S. |
2006 |
Journal of the Medical Association of Thailand 3 (89), pp. 362-367 |
||||||||
| 8. | Seizure-related injuries in northeast Thailand | Tiamkao, S. Amornsin, O. Pongchaiyakul, C. Yaudnopakao, P. Jitpimolmard, S. Arunpongpaisal, S. Phuttharak, W. Aaauevitchayapat, N. Vannaprasaht, S. Tiamkao, S. Phunikhom, K. Chaiyakum, A. Saengsuwan, J. Saetang, S. |
2006 |
Journal of the Medical Association of Thailand 5 (89), pp. 608-613 |
||||||||
| 9. | Basic knowledge of epilepsy among medical students | Tiamkao, S. Tiamkao, S. Auevitchayapat, N. Arunpongpaisal, S. Chaiyakum, A. Jitpimolmard, S. Phuttharak, W. Phunikhom, K. Saengsuwan, J. Vannaprasaht, S. |
2007 |
Journal of the Medical Association of Thailand 11 (90), pp. 2271-2276 |
||||||||
| 10. | Very high dose phenobarbital for refractory status epilepticus | Tiamkao, S. Mayurasakorn, N. Suko, P. Jitpimolmard, S. Arunpongpaisal, S. Phuttharak, W. Auevitchayapat, N. Vannaprasaht, S. Tiamkao, S. Phunikhom, K. Chaiyakum, A. Saengsuwan, J. |
2007 |
Journal of the Medical Association of Thailand 12 (90), pp. 2597-2600 |
||||||||
| 11. | Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism | Boonsrirat, U. Angsuthum, S. Vannaprasaht, S. Kongpunvijit, J. Hirankarn, N. Tassaneeyakul, W. Avihingsanon, Y. |
2008 |
Lupus 2 (17), pp. 132-134 |
||||||||
| 12. | Acute valproic acid overdose: Enhance elimination with multiple-doses activated charcoal | Vannaprasaht, S. Tiamkao, S. Sirivongs, D. Piyavhatkul, N. |
2009 |
Journal of the Medical Association of Thailand 8 (92), pp. 1113-1115 |
||||||||
| 13. | Bioequivalence study of two meloxicam tablet formulations after single-dose administration in healthy Thai male volunteers | Tangsucharit, P. Kampan, J. Kanjanawart, S. Gaysonsiri, D. Vannaprasaht, S. Tiamkao, S. Phunikhom, K. Simasathiansophon, S. Puapairoj, P. Tassaneeyakul, W. |
2009 |
International Journal of Clinical Pharmacology and Therapeutics 10 (47), pp. 638-642 |
||||||||
| 14. | Impact of the heterozygous TPMT*1/*3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in Thailand | Vannaprasaht, S. Angsuthum, S. Avihingsanon, Y. Sirivongs, D. Pongskul, C. Makarawate, P. Tassaneeyakul, W. Tassaneeyakul, W. |
2009 |
Clinical Therapeutics 7 (31), pp. 1524-1533 |
||||||||
| 15. | Predictive risk factors of seizure-related injury in persons with epilepsy | Tiamkao, S. Sawanyawisuth, K. Yaudnopakao, P. Arunpongpaisal, S. Phuttharak, W. Auevitchayapat, N. Vannaprasaht, S. Tiamkao, S. Phunikhom, K. Chaiyakum, A. Saengsuwan, J. Jitpimolmard, S. |
2009 |
Journal of the Neurological Sciences 1-2 (285), pp. 59-61 |
||||||||
| 16. | Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population | Tassaneeyakul, W. Jantararoungtong, T. Tiamkao, S. Vannaprasaht, S. Choonhakarn, C. Pisuttimarn, P. Tassaneeyakul, W. |
2009 |
Pharmacogenetics and Genomics 9 (19), pp. 704-709 |
||||||||
| 17. | The influence of CYP2A6 polymorphisms and cadmium on nicotine metabolism in Thai population | Apinan, R. Tassaneeyakul, W. Mahavorasirikul, W. Satarug, S. Vannaprasaht, S. Ruenweerayut, R. Na-Bangchang, K. |
2009 |
Environmental Toxicology and Pharmacology 3 (28), pp. 420-424 |
||||||||
| 18. | Comparative bioavailability of two risperidone orodispersible tablet products after single dose administration | Tassaneeyakul, W. Kumar, S.M. Gaysonsiri, D. Kaewkamson, T. Khuroo, A.H. Tangsucharit, P. Phunikhom, K. Vannaprasaht, S. Kanjanawart, S. Rao Thudi, N. Jain, R.K. Reyar, S. Monif, T. |
2010 |
International Journal of Clinical Pharmacology and Therapeutics 9 (48), pp. 614-620 |
||||||||
| 19. | Thiopurine S-methyltransferase pharmacogenetics: Functional characterization of a novel rapidly degraded variant allozyme | Feng, Q. Vannaprasaht, S. Angsuthum, S. Avihingsanon, Y. Tassaneeyakul, W. |
2010 |
Biochemical Pharmacology 7 (79), pp. 1053-1061 |
||||||||
| 20. | Comparative bioavailability of two sildenafil tablet formulations after single-dose administration in healthy Thai male volunteers | Kanjanawart, S. Gaysonsiri, D. Tangsucharit, P. Vannaprasaht, S. Phunikhom, K. Kaewkamson, T. Wattanachai, N. Tassaneeyakul, W. |
2011 |
International Journal of Clinical Pharmacology and Therapeutics 8 (49), pp. 525-530 |
||||||||
| 21. | HLA-B*1502 Strongly Predicts Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Thai Patients with Neuropathic Pain | Tassaneeyakul, W. Tiamkao, S. Jantararoungtong, T. Prabmechai, N. Vannaprasaht, S. Chumworathayi, P. |
2012 |
Pain Practice 3 (12), pp. 202-208 |
||||||||
| 22. | Comparative bioavailability of two moxifloxacin tablet products after single dose administration under fasting conditions in a balanced, randomized and cross-over study in healthy volunteers | Kanjanawart, S. Gaysonsiri, D. Phunikom, K. Tangsucharit, P. Vannaprasaht, S. Kaewkamson, T. Tassaneeyakul, W. |
2013 |
International Journal of Clinical Pharmacology and Therapeutics 3 (51), pp. 249-254 |
||||||||
| 23. | Personalized tacrolimus doses determined by CYP3A5 genotype for induction and maintenance phases of kidney transplantation | Vannaprasaht, S. Reungjui, S. Supanya, D. Sirivongs, D. Pongskul, C. Avihingsanon, Y. Tassaneeyakul, W. |
2013 |
Clinical Therapeutics 11 (35), pp. 1762-1769 |
||||||||
| 24. | Clinical characteristics and treatment outcomes of patients with Brugada syndrome in northeastern Thailand | Makarawate, P. Chaosuwannakit, N. Vannaprasaht, S. Tassaneeyakul, W. Sawanyawisuth, K. |
2014 |
Singapore Medical Journal 4 (55), pp. 217-220 |
||||||||
| 25. | Outcomes of symptomatic Brugada syndrome patients with implanted cardioverter defibrillators: A report from an endemic area | Makarawate, P. Chaosuwannakit, N. Vannaprasaht, S. Tassaneeyakul, W. Sawanyawisuth, K. |
2014 |
Journal of Arrhythmia 1 (30), pp. 55-57 |
||||||||
| 26. | Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions | Kongpan, T. Mahasirimongkol, S. Kanjanawart, S. Chumworathayi, P. Mootsikapun, P. Vannaprasaht, S. Tassaneayakul, W. Tassaneeyakul, W. |
2015 |
Pharmacogenetics and Genomics 8 (25), pp. 402-411 |
||||||||
| 27. | Non-BMPR2 mutation heritable pulmonary arterial hypertension in Southeast Asia | Pussadhamma, B. Kiatchoosakun, S. Vannaprasaht, S. |
2015 |
Asian Cardiovascular and Thoracic Annals 4 (23), pp. 481-483 |
||||||||
| 28. | The impact of genetic polymorphisms of drug metabolizing enzymes on the pharmacodynamics of clopidogrel under steady state conditions | Nakkam, N. Tiamkao, S. Kanjanawart, S. Tiamkao, S. Vannaprasaht, S. Tassaneeyakul, W. |
2015 |
Drug Metabolism and Pharmacokinetics 4 (30), pp. 295-304 |
||||||||
| 29. | Associations between HLA class i and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population | Tassaneeyakul, W. Kongpan, T. Chumworathayi, P. Tiamkao, S. Nakkam, N. Vannaprasaht, S. Mahasirimongkol, S. Tassaneeyakul, W. |
2016 |
Pharmacogenetics and Genomics 5 (26), pp. 225-234 |
||||||||
| 30. | Comparative pharmacodynamic effects of two clopidogrel formulations under steady-state conditions in healthy Thai volunteers | Tassaneeyakul, W. Nakkam, N. Tiamkao, S. Kanjanawart, S. Phunikhom, K. Tiamkao, S. Vannaprasaht, S. Tassaneeyakul, W. |
2017 |
International Journal of Clinical Pharmacology and Therapeutics 2 (55), pp. 177-185 |
||||||||
| 31. | Outcomes of a randomized controlled trial comparing modified high dose omeprazole and amoxicillin triple therapy with standard triple therapy for helicobacter pylori eradication | Mairiang, P. Vannaprasaht, S. Tassaneeyakul, W. Sangchan, A. Sawadpanich, K. |
2017 |
Asian Pacific Journal of Cancer Prevention 4 (18), pp. 927-932 |
||||||||
| 32. | SCN5A genetic polymorphisms associated with increased defibrillator shocks in Brugada syndrome | Makarawate, P. Chaosuwannakit, N. Vannaprasaht, S. Sahasthas, D. Tassaneeyakul, W. Sawanyawisuth, K.I. |
2017 |
Journal of the American Heart Association 6 (6), pp. |
||||||||
| 33. | The impact of non-genetic and genetic factors on a stable warfarin dose in Thai patients | Wattanachai, N. Pussadhamma, B. Makarawate, P. Wongvipaporn, C. Kiatchoosakun, S. Vannaprasaht, S. Tassaneeyakul, W. |
2017 |
European Journal of Clinical Pharmacology 8 (73), pp. 973-980 |
||||||||
| 34. | CYP2C19 loss-of-function alleles and clopidogrel hyporesponsiveness in patients with reinfarction/recurrent myocardial infarction after coronary stenting | Pussadhamma, B. Kiatchoosakun, S. Vannaprasaht, S. |
2018 |
Journal of the Medical Association of Thailand 7 (101), pp. S203-S212 |
||||||||
| 35. | Effect of CYP3A5 genotype on hospitalization cost for kidney transplantation | Vannaprasaht, S. Limwattananon, C. Anutrakulchai, Chan-On, C. |
2019 |
International Journal of Clinical Pharmacy 1 (41), pp. 88-95 |
||||||||
| 36. | Long term stability of immunophenotypic T cell subsets from whole blood of tacrolimus-based therapy kidney transplantation patients and healthy volunteers by flow cytometric analysis | Wongratanacheewin, S. Kaewraemruaen, C. Vannaprasaht, S. |
2019 |
Asia-Pacific Journal of Science and Technology 3 (24), pp. |
||||||||
| 37. | Therapeutic concentration achievement and allograft survival comparing usage of conventional tacrolimus doses and CYP3A5 genotype-guided doses in renal transplantation patients | Anutrakulchai, Pongskul, C. Kritmetapak , K Limwattananon, C. Vannaprasaht, S. |
2019 |
British Journal of Clinical Pharmacology 9 (85), pp. 1964-1973 |
||||||||
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Formation of omeprazole sulphone but not 5-hydroxyomeprazole is inhibited by grapefruit juice. | Tassaneeyakul, W Vannaprasaht, S Yamazoe, Y |
2000 |
British journal of clinical pharmacology 2 (49), pp. 139-44 |
|
| 2. | The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity. | Gorski, JC Vannaprasaht, S Hamman, MA Ambrosius, WT Bruce, MA Haehner-Daniels, B Hall, SD |
2003 |
Clinical pharmacology and therapeutics 3 (74), pp. 275-87 |
|
| 3. | Steady-state bioequivalence study of clozapine tablet in schizophrenic patients. | Tassaneeyakul, W Kittiwattanagul, K Vannaprasaht, S Kampan, J Tawalee, A Puapairoj, P Tiamkao, S Juthagridsada, S Kukongviriyapan, V Tassaneeyakul, W |
2005 |
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques 1 (8), pp. 47-53 |
|
| 4. | Knowledge of epilepsy among teachers in Khon Kaen Province, Thailand. | Tiamkao, S Aaauevitchayapat, N Arunpongpaisal, S Chaiyakum, A Jitpimolmard, S Phuttharak, W Phunikhom, K Saengsuwan, J Saetang, S Tiamkao, S Vannaprasaht, S |
2005 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 12 (88), pp. 1802-8 |
|
| 5. | Ceftazidime overdose-related nonconvulsive status epilepticus after intraperitoneal instillation. | Vannaprasaht, S Tawalee, A Mayurasakorn, N Yodwut, C Bansong, R Reungjui, S Tiamkao, S |
2006 |
Clinical toxicology (Philadelphia, Pa.) 4 (44), pp. 383-6 |
|
| 6. | Seizure presenting to the emergency department, Srinagarind Hospital. | Sawanyawisuth, K Paowana, W Saengsuwan, J Arunpongpaisal, S Chaiyakum, A Phuttharak, W Aaauevitchayapat, N Vannaprasaht, S Tiamkao, S Phunikhom, K Jitpimolmard, S |
2006 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 3 (89), pp. 362-7 |
|
| 7. | Seizure-related injuries in northeast Thailand. | Amornsin, O Pongchaiyakul, C Asawavichienjinda, T Yaudnopakao, P Jitpimolmard, S Arunpongpaisal, S Phuttharak, W Aaauevitchayapat, N Vannaprasaht, S Tiamkao, S Phunikhom, K Chaiyakum, A Saengsuwan, J Saetang, S |
2006 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 5 (89), pp. 608-13 |
|
| 8. | Basic knowledge of epilepsy among medical students. | Tiamkao, S Tiamkao, S Auevitchayapat, N Arunpongpaisal, S Chaiyakum, A Jitpimolmard, S Phuttharak, W Phunikhom, K Saengsuwan M, J Vannaprasaht, S |
2007 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 11 (90), pp. 2271-6 |
|
| 9. | Very high dose phenobarbital for refractory status epilepticus. | Tiamkao, S Mayurasakorn, N Suko, P Jitpimolmard, S Arunpongpaisal, S Phuttharak, W Auevitchayapat, N Vannaprasaht, S Tiamkao, S Phunikhom, K Chaiyakum, A Saengsuwan, J |
2007 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 12 (90), pp. 2597-600 |
|
| 10. | Comparative bioavailability of two sertraline tablet formulations after single-dose administration in healthy Thai volunteers. | Tassaneeyakul, W Kanchanawat, S Gaysonsiri, D Vannaprasath, S Paupairoj, P Kittiwattanagul, K Tippabhotla, SK Khuroo, A Panigrahy, BK Reyar, S Monif, T |
2008 |
International journal of clinical pharmacology and therapeutics 3 (46), pp. 151-6 |
|
| 11. | Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism. | Boonsrirat, U Angsuthum, S Vannaprasaht, S Kongpunvijit, J Hirankarn, N Tassaneeyakul, W Avihingsanon, Y |
2008 |
Lupus 2 (17), pp. 132-4 |
|
| 12. | The influence of CYP2A6 polymorphisms and cadmium on nicotine metabolism in Thai population. | Apinan, R Tassaneeyakul, W Mahavorasirikul, W Satarug, S Kajanawart, S Vannaprasaht, S Ruenweerayut, R Na-Bangchang, K |
2009 |
Environmental toxicology and pharmacology 3 (28), pp. 420-4 |
|
| 13. | Bioequivalence study of two meloxicam tablet formulations after single-dose administration in healthy Thai male volunteers. | Tangsucharit, P Kampan, J Kanjanawart, S Gaysonsiri, D Vannaprasaht, S Tiamkao, S Phunikhom, K Simasathiansophon, S Puapairoj, P Tassaneeyakul, W |
2009 |
International journal of clinical pharmacology and therapeutics 10 (47), pp. 638-42 |
|
| 14. | Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population. | Tassaneeyakul, W Jantararoungtong, T Chen, P Lin, PY Tiamkao, S Khunarkornsiri, U Chucherd, P Konyoung, P Vannaprasaht, S Choonhakarn, C Pisuttimarn, P Sangviroon, A Tassaneeyakul, W |
2009 |
Pharmacogenetics and genomics 9 (19), pp. 704-9 |
|
| 15. | Impact of the heterozygous TPMT*1/*3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in Thailand. | Vannaprasaht, S Angsuthum, S Avihingsanon, Y Sirivongs, D Pongskul, C Makarawate, P Praditpornsilpa, K Tassaneeyakul, W Tassaneeyakul, W |
2009 |
Clinical therapeutics 7 (31), pp. 1524-33 |
|
| 16. | Acute valproic acid overdose: enhance elimination with multiple-doses activated charcoal. | Vannaprasaht, S Tiamkao, S Sirivongs, D Piyavhatkul, N |
2009 |
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 8 (92), pp. 1113-5 |
|
| 17. | Predictive risk factors of seizure-related injury in persons with epilepsy. | Tiamkao, S Sawanyawisuth, K Asawavichienjinda, T Yaudnopakao, P Arunpongpaisal, S Phuttharak, W Auevitchayapat, N Vannaprasaht, S Tiamkao, S Phunikhom, K Chaiyakum, A Saengsuwan, J Jitpimolmard, S |
2009 |
Journal of the neurological sciences 1 (285), pp. 59-61 |
|
| 18. | Thiopurine S-methyltransferase pharmacogenetics: functional characterization of a novel rapidly degraded variant allozyme. | Feng, Q Vannaprasaht, S Peng, Y Angsuthum, S Avihingsanon, Y Yee, VC Tassaneeyakul, W Weinshilboum, RM |
2010 |
Biochemical pharmacology 7 (79), pp. 1053-61 |
|
| 19. | Comparative bioavailability of two risperidone orodispersible tablet products after single dose administration. | Tassaneeyakul, W Kumar, S Gaysonsiri, D Kaewkamson, T Khuroo, A Tangsucharit, P Phunikhom, K Vannaprasaht, S Kanjanawart, S Rao Thudi, N Jain, R Reyar, S Monif, T |
2010 |
International journal of clinical pharmacology and therapeutics 9 (48), pp. 614-20 |
|
| 20. | Comparative bioavailability of two sildenafil tablet formulations after single-dose administration in healthy Thai male volunteers. | Kanjanawart, S Gaysonsiri, D Tangsucharit, P Vannaprasaht, S Phunikhom, K Kaewkamson, T Wattanachai, N Tassaneeyakul, W |
2011 |
International journal of clinical pharmacology and therapeutics 8 (49), pp. 525-30 |
|
| 21. | HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain. | Kulkantrakorn, K Tassaneeyakul, W Tiamkao, S Jantararoungtong, T Prabmechai, N Vannaprasaht, S Chumworathayi, P Chen, P Sritipsukho, P |
2012 |
Pain practice : the official journal of World Institute of Pain 3 (12), pp. 202-8 |
|
| 22. | Comparative bioavailability of two moxifloxacin tablet products after single dose administration under fasting conditions in a balanced, randomized and cross-over study in healthy volunteers. | Kanjanawart, S Gaysonsiri, D Phunikom, K Simasathiansopon, S Tangsucharit, P Vannaprasaht, S Kaewkamson, T Tassaneeyakul, W |
2013 |
International journal of clinical pharmacology and therapeutics 3 (51), pp. 249-54 |
|
| 23. | Personalized tacrolimus doses determined by CYP3A5 genotype for induction and maintenance phases of kidney transplantation. | Vannaprasaht, S Reungjui, S Supanya, D Sirivongs, D Pongskul, C Avihingsanon, Y Tassaneeyakul, W |
2013 |
Clinical therapeutics 11 (35), pp. 1762-9 |
|
| 24. | Clinical characteristics and treatment outcomes of patients with Brugada syndrome in northeastern Thailand. | Makarawate, P Chaosuwannakit, N Vannaprasaht, S Tassaneeyakul, W Sawanyawisuth, K |
2014 |
Singapore medical journal 4 (55), pp. 217-20 |
|
| 25. | Non-BMPR2 mutation heritable pulmonary arterial hypertension in Southeast Asia. | Pussadhamma, B Kiatchoosakun, S Vannaprasaht, S Barozzi, C |
2015 |
Asian cardiovascular & thoracic annals 4 (23), pp. 481-3 |
|
| 26. | Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions. | Kongpan, T Mahasirimongkol, S Konyoung, P Kanjanawart, S Chumworathayi, P Wichukchinda, N Kidkeukarun, R Preechakul, S Khunarkornsiri, U Bamrungram, W Supharatwattanakun, B Mootsikapun, P Kwangsukstid, S Denjanta, S Vannaprasaht, S Rungapiromnan, W Suwankesawong, W Tassaneeyakul, W Tassaneeyakul, W |
2015 |
Pharmacogenetics and genomics 8 (25), pp. 402-11 |
|
| 27. | The impact of genetic polymorphisms of drug metabolizing enzymes on the pharmacodynamics of clopidogrel under steady state conditions. | Nakkam, N Tiamkao, S Kanjanawart, S Tiamkao, S Vannaprasaht, S Tassaneeyakul, W Tassaneeyakul, W |
2015 |
Drug metabolism and pharmacokinetics 4 (30), pp. 295-304 |
|
| 28. | Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population. | Tassaneeyakul, W Prabmeechai, N Sukasem, C Kongpan, T Konyoung, P Chumworathayi, P Tiamkao, S Khunarkornsiri, U Kulkantrakorn, K Saksit, N Nakkam, N Satapornpong, P Vannaprasaht, S Sangviroon, A Mahasirimongkol, S Wichukchinda, N Rerkpattanapipat, T Tassaneeyakul, W |
2016 |
Pharmacogenetics and genomics 5 (26), pp. 225-34 |
|
| 29. | The impact of non-genetic and genetic factors on a stable warfarin dose in Thai patients. | Wattanachai, N Kaewmoongkun, S Pussadhamma, B Makarawate, P Wongvipaporn, C Kiatchoosakun, S Vannaprasaht, S Tassaneeyakul, W |
2017 |
European journal of clinical pharmacology 8 (73), pp. 973-980 |
|
| 30. | Outcomes of a Randomized Controlled Trial Comparing Modified High Dose Omeprazole and Amoxicillin Triple Therapy with Standard Triple Therapy for Helicobacter Pylori Eradication | Chunlertlith, K Limpapanasit, U Mairiang, P Vannaprasaht, S Tassaneeyakul, W Sangchan, A Sawadpanich, K Suttichaimongkol, T Pongpit, J Pattarapongsin, M |
2017 |
Asian Pacific journal of cancer prevention : APJCP 4 (18), pp. 927-932 |
|
| 31. | Comparative pharmacodynamic effects of two clopidogrel formulations under steady-state conditions in healthy Thai volunteers . | Nakkam, N Tiamkao, S Kanjanawart, S Phunikhom, K Tiamkao, S Vannaprasaht, S Tassaneeyakul, W Tassaneeyakul, W |
2017 |
International journal of clinical pharmacology and therapeutics 2 (55), pp. 177-185 |
|
| 32. | Therapeutic concentration achievement and allograft survival comparing usage of conventional tacrolimus doses and CYP3A5 genotype-guided doses in renal transplantation patients. | Anutrakulchai, S Pongskul, C Kritmetapak, K Limwattananon, C Vannaprasaht, S |
2019 |
British journal of clinical pharmacology 9 (85), pp. 1964-1973 |
|
| 33. | Effect of CYP3A5 genotype on hospitalization cost for kidney transplantation. | Vannaprasaht, S Limwattananon, C Anutrakulchai, S Chan-On, C |
2019 |
International journal of clinical pharmacy 1 (41), pp. 88-95 |
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | รวม | ||||||
| 1. | The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity | JC Gorski S Vannaprasaht MA Hamman WT Ambrosius MA Bruce B Haehner-Daniels SD Hall |
2003 |
CLINICAL PHARMACOLOGY & THERAPEUTICS 3.0 (74.0), pp. 275.0-287.0 |
230 | 0 | 0 | 0 | 0 | 0 | 230 | |
| 2. | The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity (vol 74, pg 275, 2003) | JC Gorski S Vannaprasaht MA Hamman WT Ambrosius MA Bruce B Haehner-Daniels |
2004 |
CLINICAL PHARMACOLOGY & THERAPEUTICS 3.0 (75.0), pp. 249.0-249.0 |
7 | 0 | 0 | 0 | 0 | 0 | 7 | |
| 3. | Steady-state bioequivalence study of clozapine tablet in schizophrenic patients | K Kittiwattanagul S Vannaprasaht J Kampan A Tawalee P Puapairoj S Tiamkao S Juthagridsada V Kukongviriyapan W Tassaneeyakul |
2005 |
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES 1.0 (8.0), pp. 47.0-53.0 |
18 | 0 | 0 | 0 | 0 | 0 | 18 | |
| 4. | Ceftazidime overdose-related nonconvulsive status epilepticus after intraperitoneal instillation | S Vannaprasaht A Tawalee N Mayurasakorn C Yodwut R Bansong S Reungjui S Tiamkao |
2006 |
CLINICAL TOXICOLOGY 4.0 (44.0), pp. 383.0-386.0 |
20 | 0 | 0 | 0 | 0 | 0 | 20 | |
| 5. | COMPARATIVE BIOAVAILABILITY OF PHENYTOIN SUSPENSION IN THAI HEALTHY VOLUNTEERS | Suda Vannaprasaht Somsak Tiamkao Aporanee Chaiyakum Chedsada Noppawinyoowong Detpon Preechagoon Sirimas Kanjanawat Wichittra Tassaneeyakul |
2007 |
DRUG METABOLISM REVIEWS (39.0), pp. 93.0-93.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 6. | COMPARATIVE BIOAVAILABILITY OF TWO SILDENAFIL TABLET FORMULATIONS AFTER SINGLE-DOSE ADMINISTRATION IN HEALTHY THAI MALE VOLUNTEERS | Sirimas Kanjanawart Suda Vannaprasaht Panot Tangsucharit Dhanu Gaysornsiri Siriporn Tiamkao Bunkerd Kongyingyoes Roongpet Tangrassameeprasert Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2007 |
DRUG METABOLISM REVIEWS (39.0), pp. 87.0-87.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 7. | INHIBITORY EFFECT OF THAI MEDICINAL HERBS ON HUMAN CYTOCHROME P450 ACTIVITIES | Wichittra Tassaneeyakul Weeraya Dumrongsakunchai Vichien Attakornvattana Aimon Somanabandhu Suda Vannaprasaht Wongwiwat Tassaneeyakul |
2007 |
DRUG METABOLISM REVIEWS (39.0), pp. 219.0-219.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 8. | THIOPURINE S-METHYLTRANSFERASE POLYMORPHISM AS A PREDICTIVE MARKER FOR AZATHIOPRINE-INDUCED HEMATOTOXICITY IN KIDNEY TRANSPLANT RECIPIENTS | Susothorn Angsuthum Wichittra Tassaneeyakul Cholatip Pongskul Dhavee Sirivongs Wongwiwat Tassaneeyakul Yingyos Avihingsanon Suda Vannaprasaht |
2007 |
DRUG METABOLISM REVIEWS (39.0), pp. 269.0-269.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 9. | Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism | U. Boonsrirat S. Angsuthum S. Vannaprasaht J. Konapurivijit N. Hirankarn W. Tassaneeyakul Y. Avihingsanon |
2008 |
LUPUS 2.0 (17.0), pp. 132.0-134.0 |
31 | 0 | 0 | 0 | 0 | 0 | 31 | |
| 10. | Comparative bioavailability of two sertraline tablet formulations after single-dose administration in healthy Thai volunteers | W. Tassaneeyakul S. Kanchanawat D. Gaysonsiri S. Vannaprasath R. Paupairoj K. Kittiwattanagul S. K. Tippabhotla A. Khuroo B. K. Panigrahy S. Reyar T. Monif |
2008 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS 3.0 (46.0), pp. 151.0-156.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 11. | Bioequivalence study of two meloxicam tablet formulations after single-dose administration in healthy Thai male volunteers | P. Tangsucharit J. Kampan S. Kanjanawart D. Gaysonsiri S. Vannaprasaht S. Tiamkao K. Phunikhom S. Simasathiansophon P. Puapairoj W. Tassaneeyakul |
2009 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS 10.0 (47.0), pp. 638.0-642.0 |
8 | 0 | 0 | 0 | 0 | 0 | 8 | |
| 12. | Carbamazepine-the Most Common Cause of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis and an Association with HLA-B*1502 in a Thai Population | Thawinee Iantararoungtong Somsak Tiamkao Suda Vannaprasaht Kasemsin Pavakul Narong Auvichayapat Charoen Choonhakarn Wichittra Tassaneeyakul |
2009 |
DRUG METABOLISM REVIEWS (41.0), pp. 57.0-57.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 13. | Impact of the Heterozygous TPMT*1/*3C Genotype on Azathioprine-Induced Myelosuppression in Kidney Transplant Recipients in Thailand | Suda Vannaprasaht Susothorn Angsuthum Yingyos Avihingsanon Dhavee Sirivongs Cholatip Pongskul Pattarapong Makarawate Kearkiat Praditpornsilpa Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2009 |
CLINICAL THERAPEUTICS 7.0 (31.0), pp. 1524.0-1533.0 |
22 | 0 | 0 | 0 | 0 | 0 | 22 | |
| 14. | Predictive risk factors of seizure-related injury in persons with epilepsy | Somsak Tiamkao Kittisak Sawanyawisuth Thanin Asawavichienjinda Prapun Yaudnopakao Suwanna Arunpongpaisal Warinthorn Phuttharak Narong Auevitchayapat Suda Vannaprasaht Siriporn Tiamkao Kutcharin Phunikhom Aporanee Chaiyakum Jiamjit Saengsuwan Suthipun Jitpimolmard |
2009 |
JOURNAL OF THE NEUROLOGICAL SCIENCES 1-2 (285.0), pp. 59.0-61.0 |
8 | 0 | 0 | 0 | 0 | 0 | 8 | |
| 15. | PREDICTIVE RISKS OF SEIZURE-RELATED INJURY IN EPILEPTICS | K. Sawanyawisuth S. Arunpongpaisal W. Phuttharak N. Auevitchayapat S. Vannaprasaht S. Tiamkao K. Phunikhom A. Chaiyakum J. Saengsuwan |
2009 |
EPILEPSIA (50.0), pp. 165.0-165.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 16. | Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population | Wichittra Tassaneeyakul Thawinee Jantararoungtong Pei Chen Pao-Yu Lin Somsak Tiamkao Usanee Khunarkornsiri Pachadaporn Chucherd Parinya Konyoung Suda Vannaprasaht Charoen Choonhakarn Pornrith Pisuttimarn Alisara Sangviroon Wongwiwat Tassaneeyakul |
2009 |
PHARMACOGENETICS AND GENOMICS 9.0 (19.0), pp. 704.0-709.0 |
345 | 0 | 0 | 0 | 0 | 0 | 345 | |
| 17. | The influence of CYP2A6 polymorphisms and cadmium on nicotine metabolism in Thai population | Roongnapa Apinan Wichittra Tassaneeyakul Wiratchanee Mahavorasirikul Soisangwang Satarug Sirimas Kajanawart Suda Vannaprasaht Ronnatrai Ruenweerayut Kesara Na-Bangchang |
2009 |
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY 3.0 (28.0), pp. 420.0-424.0 |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 18. | Allopurinol -induced severe cutaneous adverse drug reactions in a Thai population is strongly associated with HLA-B*5801 | Wongwiwat Tassaneeyakul Somsak Tiamkao Napat Prabmeechai Thawinee Jantararoungtong Pei Chen Pao-Yu Lin Pansu Chumworathayi Usanee Khunarkornsiri Parinya Konyoung Pachadaporn Chucherd Suda Vannaprasaht Charoen Choonhakarn Alisara Sangviroon Wichittra Tassaneeyakul |
2010 |
DRUG METABOLISM REVIEWS (42.0), pp. 253.0-254.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 19. | Comparative bioavailability of two risperidone orodispersible tablet products after single dose administration | W. Tassaneeyakul S. Kumar D. Gaysonsiri T. Kaewkamson A. Khuroo P. Tangsucharit K. Phunikhom S. Vannaprasaht S. Kanjanawart N. Rao Thudi R. Jain S. Reyar T. Monif |
2010 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS 9.0 (48.0), pp. 614.0-620.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 20. | Thiopurine S-methyltransferase pharmacogenetics: Functional characterization of a novel rapidly degraded variant allozyme | Qiping Feng Suda Vannaprasaht Yi Peng Susothorn Angsuthum Yingyos Avihingsanon Vivien C. Yee Wichittra Tassaneeyakul Richard M. Weinshilboum |
2010 |
BIOCHEMICAL PHARMACOLOGY 7.0 (79.0), pp. 1053.0-1061.0 |
24 | 0 | 0 | 0 | 0 | 0 | 24 | |
| 21. | THIOPURINE S- METHYLTRANSFERASE PHARMACOGENETICS: FUNCTIONAL CHARACTERIZATION OF A NOVEL RAPIDLY DEGRADED VARIANT ALLOZYME. | Q. Feng S. Vannaprasaht Y. Peng S. Angsuthum Y. Avihingsanon V. C. Yee W. Tassaneeyakul R. M. Weinshilboum |
2010 |
CLINICAL PHARMACOLOGY & THERAPEUTICS (87.0), pp. S6-S6 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 22. | Comparative bioavailability of two sildenafil tablet formulations after single-dose administration in healthy Thai male volunteers | S. Kanjanawart D. Gaysonsiri P. Tangsucharit S. Vannaprasaht K. Phunikhom T. Kaewkamson N. Wattanachai W. Tassaneeyakul |
2011 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS 8.0 (49.0), pp. 525.0-530.0 |
18 | 0 | 0 | 0 | 0 | 0 | 18 | |
| 23. | Perinatal intraventricular hemorrhage (IVH) related to maternal warfarin | P. Komvilaisak P. Kiatchoosakun J. Jirapradittha A. Kitkhuandee S. Vannaprasaht |
2011 |
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (9.0), pp. 477.0-477.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 24. | HLA-B*1502 Strongly Predicts Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Thai Patients with Neuropathic Pain | Kongkiat Kulkantrakorn Wichittra Tassaneeyakul Somsak Tiamkao Thawinee Jantararoungtong Napat Prabmechai Suda Vannaprasaht Pansu Chumworathayi Pei Chen Paskorn Sritipsukho |
2012 |
PAIN PRACTICE 3.0 (12.0), pp. 202.0-208.0 |
73 | 0 | 0 | 0 | 0 | 0 | 73 | |
| 25. | The Common Sodium Channel Promoter Haplotype in Thai Symptomatic Brugada Syndrome Patients | Pattarapong Makarawate Narumol Chaosuwannakit Suda Vannaprasaht Koo Seok Hwee Edmund Jon Deoon Lee Wichittra Tassaneeyakul |
2012 |
CIRCULATION 23.0 (126.0), pp. 2798.0-2798.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 26. | Comparative bioavailability of two moxifloxacin tablet products after single dose administration under fasting conditions in a balanced, randomized and cross-over study in healthy volunteers | Sirimas Kanjanawart Dhanu Gaysonsiri Katcharin Phunikom Sontaya Simasathiansopon Panot Tangsucharit Suda Vannaprasaht Thanawat Kaewkamson Wichittra Tassaneeyakul |
2013 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS 3.0 (51.0), pp. 249.0-254.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 27. | Personalized Tacrolimus Doses Determined by CYP3A5 Genotype for Induction and Maintenance Phases of Kidney Transplantation | Suda Vannaprasaht Sirirat Reungjui Darika Supanya Dhavee Sirivongs Cholatip Pongskul Yingyos Avihingsanon Wichittra Tassaneeyakul |
2013 |
CLINICAL THERAPEUTICS 11.0 (35.0), pp. 1762.0-1769.0 |
31 | 0 | 0 | 0 | 0 | 0 | 31 | |
| 28. | SCN5A (H558R) gene mutation is associated with appropriate shock therapy in Thai Brugada syndrome patients receiving AICD treatment | P. Makarawate N. Chaosuwannakit S. Vannaprasaht K. Sawanyawisuth K. Seok Hwee E. Deoon Lee W. Tassaneeyakul |
2013 |
EUROPEAN HEART JOURNAL (34.0), pp. 424.0-424.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 29. | Clinical characteristics and treatment outcomes of patients with Brugada syndrome in northeastern Thailand | Pattarapong Makarawate Narumol Chaosuwannakit Suda Vannaprasaht Wichittra Tassaneeyakul Kittisak Sawanyawisuth |
2014 |
SINGAPORE MEDICAL JOURNAL 4.0 (55.0), pp. 217.0-220.0 |
12 | 0 | 0 | 0 | 0 | 0 | 12 | |
| 30. | Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions | Thachanan Kongpan Surakameth Mahasirimongkol Parinya Konyoung Sirimas Kanjanawart Pansu Chumworathayi Nuanjun Wichukchinda Runglak Kidkeukarun Suphanlinee Preechakul Usanee Khunarkornsiri Warawut Bamrungram Butsaban Supharatwattanakun Piroon Mootsikapun Supanida Kwangsukstid Sukanda Denjanta Suda Vannaprasaht Watcharee Rungapiromnan Wimon Suwankesawong Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2015 |
PHARMACOGENETICS AND GENOMICS 8.0 (25.0), pp. 402.0-411.0 |
39 | 1 | 0 | 0 | 0 | 0 | 40 | |
| 31. | Genetic Markers for Severe Cutaneous Adverse Drug Reactions of Phenytoin | S. Tiamkao N. Prabmeechai P. Konyoung P. Chumworathayi C. Sukasem T. Kongpan N. Saksit A. Sangviroon S. Vannaprasath S. Kanjanawat N. Wichukchinda S. Mahasirimongkol W. Inunchot N. Chaiyakunapruk W. Tassaneeyakul |
2015 |
PUBLIC HEALTH GENOMICS (18.0), pp. 5.0-5.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 32. | The Effect of Genetic Polymorphism of CYP2C9 on Phenytoin Dosage Requirement in Thai Epileptic Patients | S. Vannaprasaht P. Sirisawat P. Chiewthanakul S. Tiamkao W. Tassaneeyakul |
2015 |
PUBLIC HEALTH GENOMICS (18.0), pp. 13.0-14.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 33. | The impact of genetic polymorphisms of drug metabolizing enzymes on the pharmacodynamics of clopidogrel under steady state conditions | Nontaya Nakkam Somsak Tiamkao Sirimas Kanjanawart Siriporn Tiamkao Suda Vannaprasaht Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2015 |
DRUG METABOLISM AND PHARMACOKINETICS 4.0 (30.0), pp. 295.0-304.0 |
6 | 0 | 0 | 0 | 0 | 0 | 6 | |
| 34. | Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population | Wichittra Tassaneeyakul Napat Prabmeechai Chonlaphat Sukasem Thachanan Kongpan Parinya Konyoung Pansu Chumworathayi Somsak Tiamkao Usanee Khunarkornsiri Kongkiat Kulkantrakorn Niwat Saksit Nontaya Nakkam Patompong Satapornpong Suda Vannaprasaht Alisara Sangviroon Surakameth Mahasirimongkol Nuanjun Wichukchinda Ticha Rerkpattanapipat Wongwiwat Tassaneeyakul |
2016 |
PHARMACOGENETICS AND GENOMICS 5.0 (26.0), pp. 225.0-234.0 |
65 | 0 | 0 | 0 | 0 | 0 | 65 | |
| 35. | Modified High Dose Omeprazole and Amoxicillin Triple Therapy Compare to Standard Triple Therapy in Helicobacter pylori Eradication | Uaepong Limpapanasit Pisaln Mairiang Kitti Chunlertlith Wattana Sukeepaisarnjaroen Suda Vannaprasaht Wichittra Tassaneeyakul Apichat Sangchan Kookwan Sawadpanich Tanita Suttichaimongkol |
2016 |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (31.0), pp. 78.0-78.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 36. | Comparative pharmacodynamic effects of two clopidogrel formulations under steady-state conditions in healthy Thai volunteers | Nontaya Nakkam Somsak Tiamkao Sirimas Kanjanawart Kutcharin Phunikhom Siriporn Tiamkao Suda Vannaprasaht Wongwiwat Tassaneeyakul Wichittra Tassaneeyakul |
2017 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS 2.0 (55.0), pp. 177.0-185.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 37. | CYP2C9*3 VARIANT IS ASSOCIATED WITH PHENYTOIN-RELATED SEVERE CUTANEOUS ADVERSE REACTIONS IN A THAI POPULATION | Wichittra Tassaneeyakul Parinya Konyoung Thachanan Kongpan Pansu Chumworathayi Nontaya Nakkam Suda Vannaprasaht Somsak Tiamkao Chonlaphat Sukasem Patompong Satapornpong Wongwiwat Tassaneeyakul |
2017 |
DRUG METABOLISM AND PHARMACOKINETICS 1.0 (32.0), pp. S85-S86 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 38. | SCN5A Genetic Polymorphisms Associated With Increased Defibrillator Shocks in Brugada Syndrome | Pattarapong Makarawate Narumol Chaosuwannakit Suda Vannaprasaht Dujdao Sahasthas Seok Hwee Koo Edmund Jon Deoon Lee Wichittra Tassaneeyakul Hector Barajas-Martinez Dan Hu Kittisak Sawanyawisuth |
2017 |
JOURNAL OF THE AMERICAN HEART ASSOCIATION 6.0 (6.0), pp. |
15 | 0 | 0 | 0 | 0 | 0 | 15 | |
| 39. | The impact of non-genetic and genetic factors on a stable warfarin dose in Thai patients | Nitsupa Wattanachai Sutthida Kaewmoongkun Burabha Pussadhamma Pattarapong Makarawate Chaiyasith Wongvipaporn Songsak Kiatchoosakun Suda Vannaprasaht Wichittra Tassaneeyakul |
2017 |
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 8.0 (73.0), pp. 973.0-980.0 |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 40. | Effect of CYP3A5 genotype on hospitalization cost for kidney transplantation | Suda Vannaprasaht Chulaporn Limwattananon Sirirat Anutrakulchai Chitranon Chan-on |
2019 |
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY 1.0 (41.0), pp. 88.0-95.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 41. | Therapeutic concentration achievement and allograft survival comparing usage of conventional tacrolimus doses and CYP3A5 genotype-guided doses in renal transplantation patients | Sirirat Anutrakulchai Cholatip Pongskul Kittrawee Kritmetapak Chulaporn Limwattananon Suda Vannaprasaht |
2019 |
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 9.0 (85.0), pp. 1964.0-1973.0 |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 42. | Intravascular hemolysis and methemoglobinemia from malacca fruit (Phyllanthus emblica) wine | Thapanawong Mitsungnern Nuttaphong Bummrungjitt Nattapat Wongtirawit Praew Kotruchin Suda Vannaprasaht |
2020 |
CLINICAL TOXICOLOGY 4.0 (58.0), pp. 332.0-333.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 43. | Total ophthalmoplegia with divergent gaze following severe amitriptyline toxicity: a case report | T. Mitsungnern N. Bummroongjitt N. Srimakam P. Kotruchin S. Vannaprasaht |
2020 |
CLINICAL TOXICOLOGY 4.0 (58.0), pp. 334.0-334.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Bioequivalence of Clozapine Tablet in Thai Schizophrenic Patients | Wichittra Tassaneeyakul Khanogwan Kittiwattanagul Siriporn Tiamkao Jureeporn Kampan Suda Vannaprasaht Wannapa Haewdee Prapawadee Puapairoj Bunkerd Kongyingyoes Wongwiwat Tassaneeyakul |
2007 |
Srinagarind Medical Journal (22 No 1), pp. 16-23 |
|
| 2. | Bioequivalence and Pharmacokinetic Study of Sildenafil in Healthy Thai Male Volunteers | Sirimas Kanjanawart Bunkerd Kongyingyoes Dhanu Gaysornsiri Panot Tangsucharit Prapawadee Puapairoj Suda Vannaprasaht Siriporn Tiamkao Wichittra Tassaneeyakul |
2008 |
Srinagarind Medical Journal (23 No 1), pp. 38-44 |
|
| 3. | Bioequivalence of 400 mg Moxifloxacin Tablet in Healthy Thai Volunteers | Sirimas Kanjanawart Sontaya Simasathiansopon Prapawadee Paupairoj Suda Vannaprasath Siriporn Tiamkao Dhanu Gaysonsiri Panot Tangsucharit Thanawat Kaewkamson Wichittra Tassaneeyakul |
2010 |
Thai Journal of Pharmacology (32 No 1), pp. 253-255 |
|
| 4. | Pharmacokinetic Study and Therapeutic Drug Monitoring of Vancomycin in End Stage Renal Disease Patients | Teerapon Bootprom Weerapong Thumchotang Denpong Patanasethanont Aporanee Chaiyakum Siriluk Jaisue Suda Vannaprasaht |
2014 |
Isan Journal of Pharmaceutical Sciences (9 No 3), pp. 185 |
|
| 5. | The Effect of CytidineDeaminase Polymorphisms on Hematotoxicity in Thai Cancer Patients Treated with Gemcitabine-based Chemotherapy | Duanggamon Muengsaen Suda Vannaprasaht Wichittra Tassaneeyakul Kritiya Butthongkomvong Thipawan Bowornkitiwong Luangyot Thongthieang Parichart Pongthai Kosin Wirasorn Aumkhae Sookprasert |
2016 |
Srinagarind Medical Journal (31 No 5), pp. 105-108 |
| ชื่อโครงการ | Authors | ประเภทโครงการ | ปีงบประมาณ | ทุนวิจับ |
|---|